Prescribing restrictions for triple therapy in COPD
We are pleased to announce that our study, exploring barriers to accessing triple therapy for COPD management in primary care across Europe, was presented at the 12th International Care Respiratory Group (IPCRG) World Conference in Athens. The research looked at the variation in the pharmacological management of COPD due to payer-driven access criteria for triple Read More >
Identifying the common barriers to optimal COPD care in Japan, Canada, England, and Germany through Evidenced Care Pathways
Analysing the COPD care pathway in Japan, Canada, England, and Germany: a global view
